The year two thousand and t was an ominous one for emerging infectious diseases. Many experts feared they were watching the start of a glob pandemic. The scientific community really should have developed universal anti virals against tars, says robert webster,. Then we would have had something in the stock pile for the emergence of covid he says. Covid is caused by sars, cove too, a close relative of the virus responsible for sars. But with the pharmaseutical industry historically focused on just a few particular virises, h i v and hepotitis c, mostly, finding agents to fight known and imagined threats remains at all order.
Despite warnings, and a number of close calls, drugmakers failed to develop and stockpile drugs to fight a viral pandemic. Now, in the wake of SARS-CoV-2, they are pledging not to make the same mistake again.
Around the world, researchers are racing to develop drugs to target COVID-19, but also broad-spectrum antivirals that could be used to treat future viral threats.
This is an audio version of our feature: The race for antiviral drugs to beat COVID — and the next pandemic
Hosted on Acast. See acast.com/privacy for more information.